Within five years, we estimate that Daiichi Sankyo will generate over one third of total sales in the US, so major pricing reforms in this market will weigh on projected sales and margins.

As one of the leading Japanese pharmaceutical companies with headquarters in Europe, Daiichi Sankyo aims to revolutionize treatment standards. Daiichi Sankyo, a pharmaceutical group boasting over ...

owned by RHC Healthcare Management Services Pvt Ltd which is one of the judgment debtors in the matter. The application was filed in a petition by Daiichi Sankyo seeking execution of a ₹3,500 ...

Together, the three ADCs are billed as one of the strategic pillars of Daiichi Sankyo's current five-year business plan to 2025. Plexxikon's targeted drugs have been modest sellers, with Zelboraf ...

This time, Lee has emphasized that Sugar Hill Steward’s voice will be the primary one to prevent distractions. “‘Suga’ should have been the only voice, and he will be the only voice in the ...

Night 4 of Battles on The Voice spotlighted four new duels, including what one coach called “the performance of the night,” and featured another epic “steal.” Tuesday’s condensed episode ...

The Voice UK came to a conclusion last night on ... She took to the stage with her coaches Danny Jones and Tom Fletcher, as she performed one last time and was met by confetti and thunderous ...

The three phase 3 trials are TROPION-Lung10, TROPION-Lung14 and TROPION-Lung15, according to a press release from Daiichi Sankyo, one of the developers of the drug. Dato-DXd is a TROP2-directed ...

Daiichi Sankyo has made a little bit of pharma industry ... which showed that Delytact boosted the one-year survival rate in patients with residual or recurrent glioblastoma who had been treated ...